Pharmacokinetics, pharmacodynamics and pharmacogenetics associated with nonsteroidal anti-inflammatory drugs and opioids in pediatric cancer patients

References

• Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49(8–31):1.
   Google Scholar
• Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342:326–333.
   PubMed Web of Science ®Google Scholar
• Friedrichsdorf SJ, Postier A. Management of breakthrough pain in children with cancer. J Pain Res. 2014;7:117–123.
   PubMed Web of Science ®Google Scholar
• Gans D, Hadler MW, Chen X, et al. Cost analysis and policy implications of a pediatric palliative care program. J Pain Symptom Manage. 2016;52:329–335.
   PubMed Web of Science ®Google Scholar
• Mercadante S. Cancer pain management in children. Palliat Med. 2004;18:654–662.
   PubMed Web of Science ®Google Scholar
• Miser AW, McCalla J, Dothage JA, et al. Pain as a presenting symptom in children and young adults with newly diagnosed malignancy. Pain. 1987;29:85–90.
   PubMed Web of Science ®Google Scholar
• Zernikow B, Smale H, Michel E, et al. Paediatric cancer pain management using the WHO analgesic ladder – results of a prospective analysis from 2265 treatment days during a quality improvement study. Eur J Pain. 2006;10:587–595.
   PubMed Web of Science ®Google Scholar
• Stjernsward J. WHO cancer pain relief programme. Cancer Surv. 1988;7:195–208.
   PubMedGoogle Scholar
• Cancer pain relief and palliative care in children. Geneva: World Health Organization; 1998.
   Google Scholar
• Geeta MG, Geetha P, Ajithkumar VT, et al. Management of pain in leukemic children using the WHO analgesic ladder. Indian J Pediatr. 2010;77:665–668.
   PubMed Web of Science ®Google Scholar
• Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician. 2010;56(514–7):e202–5.
   Google Scholar
• Zech DF, Grond S, Lynch J, et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:65–76.
   PubMed Web of Science ®Google Scholar
• Ljungman G, Gordh T, Sorensen S, et al. Pain variations during cancer treatment in children: a descriptive survey. Pediatr Hematol Oncol. 2000;17:211–221.
   PubMed Web of Science ®Google Scholar
• Flogegard H, Ljungman G. Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting. Med Pediatr Oncol. 2003;40:233–238.
   PubMedGoogle Scholar
• Oakes LL, Anghelescu DL, Windsor KB, et al. An update: institutional quality improvement initiative for pain management for pediatric cancer inpatients, 2007-2010. J Pain Symptom Manage. 2011;41:e4–6.
   PubMed Web of Science ®Google Scholar
• WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses. Geneva: World HealthOrganization. 2012.
   Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65:1–49.
   PubMed Web of Science ®Google Scholar
• Schechter NL, Walco GA. The potential impact on children of the CDC guideline for prescribing opioids for chronic pain: above all, do no harm. JAMA Pediatr. 2016;170:425–426.
   PubMed Web of Science ®Google Scholar
• Collins JJ, Stevens MM, Berde CB. Pediatric cancer pain. In: Rice ASC, editor. Clinical pain management. London: Hodder Arnold; 2008.
   Google Scholar
• Tolbert J, Kearns GL. The challenge of obesity in paediatric leukaemia treatment: it is not just size that matters. Arch Dis Child. 2015;100:101–105.
   PubMed Web of Science ®Google Scholar
• Renton KW. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther. 2001;92:147–163.
   PubMed Web of Science ®Google Scholar
• Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab. 2004;5:235–243.
   PubMed Web of Science ®Google Scholar
• Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003;4:224–232.
   PubMed Web of Science ®Google Scholar
• Suno M, Endo Y, Nishie H, et al. Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients. Ther Clin Risk Manag. 2015;11:751–757.
   PubMed Web of Science ®Google Scholar
• Carcillo JA, Doughty L, Kofos D, et al. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med. 2003;29:980–984.
   PubMed Web of Science ®Google Scholar
• Vet NJ, De Hoog M, Tibboel D, et al. The effect of inflammation on drug metabolism: a focus on pediatrics. Drug Discovery Today. 2011;16:435–442.
   PubMed Web of Science ®Google Scholar
• Scripture CD, Sparreboom A, Figg WD. Modulation of cytochrome P450 activity: implications for cancer therapy. Lancet Oncol. 2005;6:780–789.
   PubMed Web of Science ®Google Scholar
• Morgan ET. Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther. 2009;85:434–438.
   PubMed Web of Science ®Google Scholar
• Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol. 2006;46:123–149.
   PubMed Web of Science ®Google Scholar
• Petrovic V, Teng S, Piquette-Miller M. Regulation of drug transporters during infection and inflammation. Mol Interv. 2007;7:99–111.
   PubMed Web of Science ®Google Scholar
• Morgan ET, Goralski KB, Piquette-Miller M, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 2008;36:205–216.
   PubMed Web of Science ®Google Scholar
• Piquette-Miller M, Pak A, Kim H, et al. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm Res. 1998;15:706–711.
   PubMed Web of Science ®Google Scholar
• Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol. 2001;1:189–199.
   PubMed Web of Science ®Google Scholar
• Kacevska M, Mahns A, Sharma R, et al. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling. Pharm Res. 2013;30:2270–2278.
   PubMed Web of Science ®Google Scholar
• Ikemura K, Urano K, Matsuda H, et al. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells. J Pharmacol Exp Ther. 2009;328:249–255.
   PubMed Web of Science ®Google Scholar
• Thorling CA, Roberts MS, Liu X, et al. Effects of long-term hepatic ischemia-reperfusion injury on the function of P-glycoprotein in vivo in rats. J Pharm Pharm Sci. 2014;17:121–135.
   PubMed Web of Science ®Google Scholar
• Friedrichsdorf SJ, Nugent AP. Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013;7:131–138.
   PubMed Web of Science ®Google Scholar
• Bookstaver PB, Miller AD, Rudisill CN, et al. Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res. 2010;3:67–79.
   PubMedGoogle Scholar
• Bookstaver PB, Norris L, Rudisill C, et al. Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis. Am J Health Syst Pharm. 2008;65:2117–2121.
   PubMed Web of Science ®Google Scholar
• Kokki H, Kumpulainen E, Lehtonen M, et al. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics. 2007;120:e1002–8.
   PubMed Web of Science ®Google Scholar
• Troconiz IF, Armenteros S, Planelles MV, et al. Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet. 2000;38:505–518.
   PubMed Web of Science ®Google Scholar
• Kauffman RE, Nelson MV. Effect of age on ibuprofen pharmacokinetics and antipyretic response. J Pediatr. 1992;121:969–973.
   PubMed Web of Science ®Google Scholar
• Azeemuddin SK, Vega RA, Kim TH, et al. The effect of naproxen on fever in children with malignancies. Cancer. 1987;59:1966–1968.
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, Knockaert DC, Peetermans WE, et al. Lack of value of the naproxen test in the differential diagnosis of prolonged febrile illnesses. Am J Med. 2003;115:572–575.
   PubMed Web of Science ®Google Scholar
• Marzuillo P, Guarino S, Barbi E. Paracetamol: a focus for the general pediatrician. Eur J Pediatr. 2014;173:415–425.
   PubMed Web of Science ®Google Scholar
• Bagnall WE, Kelleher J, Walker BE, et al. The gastrointestinal absorption of paracetamol in the rat. J Pharm Pharmacol. 1979;31:157–160.
   PubMed Web of Science ®Google Scholar
• Cook SF, Stockmann C, Samiee-Zafarghandy S, et al. Neonatal maturation of paracetamol (acetaminophen) glucuronidation, sulfation, and oxidation based on a parent-metabolite population pharmacokinetic model. Clin Pharmacokinet. 2016.
   Web of Science ®Google Scholar
• Cook SF, Roberts JK, Samiee-Zafarghandy S, et al. Population pharmacokinetics of intravenous paracetamol (acetaminophen) in preterm and term neonates: model development and external evaluation. Clin Pharmacokinet. 2016;55:107–119.
   PubMed Web of Science ®Google Scholar
• De Martino M, Chiarugi A. Recent advances in pediatric use of oral paracetamol in fever and pain management. Pain Ther. 2015;4:149–168.
   PubMedGoogle Scholar
• Litalien C, Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol. Paediatr Drugs. 2001;3:817–858.
   PubMedGoogle Scholar
• Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child. 2008;93:241–247.
   PubMed Web of Science ®Google Scholar
• Brett CN, Barnett SG, Pearson J. Postoperative plasma paracetamol levels following oral or intravenous paracetamol administration: a double-blind randomised controlled trial. Anaesth Intensive Care. 2012;40:166–171.
   PubMed Web of Science ®Google Scholar
• Crews KR, Gaedigk A, Dunnenberger HM, et al. Clinical pharmacogenetics implementation c. clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther. 2014;95:376–382.
   PubMed Web of Science ®Google Scholar
• Williams DG, Hatch DJ, Howard RF. Codeine phosphate in paediatric medicine. Br J Anaesth. 2001;86:413–421.
   PubMed Web of Science ®Google Scholar
• “Weak” opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine. Prescrire Int. 2016;25:45–50.
   PubMedGoogle Scholar
• Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002;89:839–845.
   PubMed Web of Science ®Google Scholar
• Madadi P, Koren G. Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. Pharmacogenomics. 2008;9:1267–1284.
   PubMed Web of Science ®Google Scholar
• Wong C, Lau E, Palozzi L, et al. Pain management in children: part 2 – a transition from codeine to morphine for moderate to severe pain in children. Can Pharm J (Ott). 2012;145(276–9):e1.
   PubMedGoogle Scholar
• Rose JB, Finkel JC, Arquedas-Mohs A, et al. Oral tramadol for the treatment of pain of 7-30 days’ duration in children. Anesth Analg. 2003;96:78–81. table of contents.
   PubMed Web of Science ®Google Scholar
• Houmes RJ, Voets MA, Verkaaik A, et al. Efficacy and safety of tramadol versus morphine for moderate and severe postoperative pain with special regard to respiratory depression. Anesth Analg. 1992;74:510–514.
   PubMed Web of Science ®Google Scholar
• Marincsak R, Toth BI, Czifra G, et al. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1. Anesth Analg. 2008;106:1890–1896.
   PubMed Web of Science ®Google Scholar
• Hunt A, Joel S, Dick G, et al. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr. 1999;135:47–55.
   PubMed Web of Science ®Google Scholar
• Greene RF, Miser AW, Lester CM, et al. Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. Pain. 1987;30:339–348.
   PubMed Web of Science ®Google Scholar
• Kart T, Christrup LL, Rasmussen M. Recommended use of morphine in neonates, infants and children based on a literature review: part 1 – pharmacokinetics. Paediatr Anaesth. 1997;7:5–11.
   PubMed Web of Science ®Google Scholar
• Dampier CD, Setty BN, Logan J, et al. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr. 1995;126:461–467.
   PubMed Web of Science ®Google Scholar
• Komatsu T, Kokubun H, Suzuki A, et al. Population pharmacokinetics of oxycodone in patients with cancer-related pain. J Pain Palliat Care Pharmacother. 2012;26:220–225.
   PubMedGoogle Scholar
• El-Tahtawy A, Kokki H, Reidenberg BE. Population pharmacokinetics of oxycodone in children 6 months to 7 years old. J Clin Pharmacol. 2006;46:433–442.
   PubMed Web of Science ®Google Scholar
• Kokki H, Rasanen I, Lasalmi M, et al. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clin Pharmacokinet. 2006;45:745–754.
   PubMed Web of Science ®Google Scholar
• Stanley TH. Fentanyl. J Pain Symptom Manage. 2005;29:S67–71.
   PubMed Web of Science ®Google Scholar
• Nagel K, Willan AR, Lappan J, et al. Pediatric oncology sedation trial (POST): a double-blind randomized study. Pediatr Blood Cancer. 2008;51:634–638.
   PubMed Web of Science ®Google Scholar
• Drake R, Longworth J, Collins JJ. Opioid rotation in children with cancer. J Palliat Med. 2004;7:419–422.
   PubMedGoogle Scholar
• Koren G, Goresky G, Crean P, et al. Pediatric fentanyl dosing based on pharmacokinetics during cardiac surgery. Anesth Analg. 1984;63:577–582.
   PubMed Web of Science ®Google Scholar
• Chiaretti A, Viola L, Pietrini D, et al. Preemptive analgesia with tramadol and fentanyl in pediatric neurosurgery. Childs Nerv Syst. 2000;16:93–99. discussion 100.
   PubMed Web of Science ®Google Scholar
• Mireskandari SM, Abulahrar N, Darabi ME, et al. Comparison of the effect of fentanyl, sufentanil, alfentanil and remifentanil on cardiovascular response to tracheal intubation in children. Iran J Pediatr. 2011;21:173–180.
   PubMed Web of Science ®Google Scholar
• O’Mahony S, Coyle N, Payne R. Current management of opioid-related side effects. Oncology (Williston Park). 2001;15:61–73. 7; discussion 7-8, 80-2.
   PubMed Web of Science ®Google Scholar
• Noyes M, Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care. 2001;18:411–416.
   PubMedGoogle Scholar
• FDA. IONSYS (fentanyl inotophoretic transdermal system) product label. www.acessdata.fda.gov2006.
   Google Scholar
• Murphy A, O’Sullivan R, Wakai A, et al. Intranasal fentanyl for the management of acute pain in children. Cochrane Database Syst Rev. 2014;10:CD009942.
   Google Scholar
• Foster D, Upton R, Christrup L, et al. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Ann Pharmacother. 2008;42:1380–1387.
   PubMed Web of Science ®Google Scholar
• Karas-Trzeciak M, Grabowski T, Woloszczuk-Gebicka B, et al. Fentanyl with ropivacaine infusion for postoperative pain relief in infants and children. Kinetics of Epidural Fentanyl. Paediatr Anaesth. 2015;25:818–823.
   PubMed Web of Science ®Google Scholar
• Paech MJ, Bloor M, Schug SA. New formulations of fentanyl for acute pain management. Drugs Today (Barc). 2012;48:119–132.
   PubMed Web of Science ®Google Scholar
• Collins JJ, Dunkel IJ, Gupta SK, et al. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr. 1999;134:319–323.
   PubMed Web of Science ®Google Scholar
• Othman AH, Mohamad MF, Sayed HA. Transdermal fentanyl for cancer pain management in opioid-naive pediatric cancer patients. Pain Med. 2016.
   PubMed Web of Science ®Google Scholar
• Finkel JC, Finley A, Greco C, et al. Transdermal fentanyl in the management of children with chronic severe pain: results from an international study. Cancer. 2005;104:2847–2857.
   PubMed Web of Science ®Google Scholar
• Zernikow B, Michel E, Anderson B. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain. 2007;8:187–207.
   PubMed Web of Science ®Google Scholar
• Ginsberg B, Howell S, Glass PS, et al. Pharmacokinetic model-driven infusion of fentanyl in children. Anesthesiology. 1996;85:1268–1275.
   PubMed Web of Science ®Google Scholar
• Wheeler M, Birmingham PK, Dsida RM, et al. Uptake pharmacokinetics of the Fentanyl Oralet in children scheduled for central venous access removal: implications for the timing of initiating painful procedures. Paediatr Anaesth. 2002;12:594–599.
   PubMed Web of Science ®Google Scholar
• Wheeler M, Birmingham PK, Lugo RA, et al. The pharmacokinetics of the intravenous formulation of fentanyl citrate administered orally in children undergoing general anesthesia. Anesth Analg. 2004;99:1347–1351. table of contents.
   PubMed Web of Science ®Google Scholar
• Dsida RM, Wheeler M, Birmingham PK, et al. Premedication of pediatric tonsillectomy patients with oral transmucosal fentanyl citrate. Anesth Analg. 1998;86:66–70.
   PubMed Web of Science ®Google Scholar
• Song IK, Park YH, Lee JH, et al. Randomized controlled trial on preemptive analgesia for acute postoperative pain management in children. Paediatr Anaesth. 2016;26:438–443.
   PubMed Web of Science ®Google Scholar
• Katz R, Kelly HW. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med. 1993;21:995–1000.
   PubMed Web of Science ®Google Scholar
• Solanki NM, Engineer SR, Jansari DB, et al. Comparison of caudal tramadol versus caudal fentanyl with bupivacaine for prolongation of postoperative analgesia in pediatric patients. Saudi J Anaesth. 2016;10:154–160.
   PubMed Web of Science ®Google Scholar
• Singleton MA, Rosen JI, Fisher DM. Plasma concentrations of fentanyl in infants, children and adults. Can J Anaesth. 1987;34:152–155.
   PubMed Web of Science ®Google Scholar
• Hertzka RE, Gauntlett IS, Fisher DM, et al. Fentanyl-induced ventilatory depression: effects of age. Anesthesiology. 1989;70:213–218.
   PubMed Web of Science ®Google Scholar
• Administration USFaD. Executive summary of clinical and clinical pharmacology and biopharmaceutics reviews: Duragesic. Supplement to NDA. 2002;19–813.
   Google Scholar
• Ostwal S, Salins N, Deodhar J, et al. Fentanyl-induced neurotoxicity in children. J Pain Palliat Care Pharmacother. 2015;29:385–387.
   PubMedGoogle Scholar
• Definitions for genomic biomarkers, pharmacogenomics, pharmacogenetics. Genomic data and sample coding categories E15. European Medicines Agency. 2007.
   Google Scholar
• Feinstein J, Dai D, Zhong W, et al. Potential drug-drug interactions in infant, child, and adolescent patients in children’s hospitals. Pediatrics. 2015;135:e99–108.
   PubMed Web of Science ®Google Scholar
• Brockmoller J, Tzvetkov MV. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Eur J Clin Pharmacol. 2008;64:133–157.
   PubMed Web of Science ®Google Scholar
• Mini E, Nobili S. Pharmacogenetics: implementing personalized medicine. Clin Cases Miner Bone Metab. 2009;6:17–24.
   PubMedGoogle Scholar
• Court MH. A pharmacogenomics primer. J Clin Pharmacol. 2007;47:1087–1103.
   PubMed Web of Science ®Google Scholar
• McGrath PA. Development of the World Health Organization guidelines on cancer pain relief and palliative care in children. J Pain Symptom Manage. 1996;12:87–92.
   PubMed Web of Science ®Google Scholar
• Neuman MG, Cameron RG, Haber JA, et al. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity. Clin Biochem. 1999;32:519–536.
   PubMed Web of Science ®Google Scholar
• Jacob E, Puntillo KA. Variability of analgesic practices for hospitalized children on different pediatric specialty units. J Pain Symptom Manage. 2000;20:59–67.
   PubMed Web of Science ®Google Scholar